Galapagos NV (EUR)
GLPG
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range189.00 | 192.85
52-Wk Range74.48 | 189.25
Last Close188.70
Mkt Cap (m)12,202.63
Dividend yield-
ISINBE0003818359
Volume727,765
Exchange VenueAMS

Company Profile

Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions.

Key Information
Price/Earning38.59
Price/Book4.81
Price/Sales12.91
P/CF3.27
Rev Growth (3 year avg)93.99
EPS Growth (3 year avg)-
Operating Margin % -15.51
Net Margin %-10.13
Return on Equity-2.63
Debt/Equity0.00

Legal Documents

Prospectus
en 15/10/2018
Annual Report
en 31/12/2018

Financials

Income Statement
EUR201320142015201620172018
Revenue (m)1386940130127289
Operating Income (m)-10-36-89-11-90-45
Net Income (m)-833-11854-116-29
Basic EPS-0.281.10-3.321.18-2.34-0.56
Avg. Diluted Shares Outstanding (m)293036464952
Balance Sheet
EUR201320142015201620172018
Current Assets (m)1772143741,0071,1981,329
Non Current Assets (m)11157687689111
Total Assets (m)2872704431,0831,2861,439
Current Liabilities (m)1136072104172220
Total Liabilities (m)------
Total Equity (m)1672063657591,0121,214
Cash Flows
EUR201320142015201620172018
Operating Cash Flows (m)1-76-115239-147-142
Capital Expenditure (m)-8-3-7-5-7-14
Figures are quoted in EUR unless stated otherwise
3.40 (1.80%)
192.10
Last Price